How Novartis Is Tailoring Its Strategy In Asia Pacific, Middle East and Africa

Iris Zemzoum, Novartis Pharma's president for Asia Pacific, Middle East and Africa, outlines how the company is shaping its strategy in the region, which comes with “extremes” in market profiles, via a distinct archetype that factors in commonalities between national healthcare systems. The company is also progressing interesting initiatives in digital therapeutics.

Iris Zemzoum, President, Novartis Pharma, APMA — Iris Zemzoum, President, Novartis Pharma, Asia Pacific, Middle East and Africa • Source: Novartis

Novartis AG is deploying a distinct strategic model across the Asia Pacific, Middle East and Africa (APMA) as it sharpens efforts to expand access to treatments alongside driving growth and influence in the huge region, which covers over 30 markets.

In a wide-ranging interview with Scrip, Iris Zemzoum, Novartis Pharma's president for APMA, highlighted the complexity and diversity of the...